MedPath
HSA Approval

DEPLATT TABLET 75MG

SIN13820P

DEPLATT TABLET 75MG

DEPLATT TABLET 75MG

June 24, 2010

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

B01AC04

clopidogrel

Manufacturer Information

APOTHECA MARKETING PTE LTD

Torrent Pharmaceuticals Limited

Active Ingredients

CLOPIDOGREL HYDROGEN SULFATE 97.875 mg EQV CLOPIDOGREL

75 mg

Clopidogrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEPLATT TABLET 75MG - HSA Approval | MedPath